MENU
ACB
AS OF
Mar 5, 04:59 PM (EDT)
Price
$3.52
Change
-$0.13 (-3.56%)
Capitalization
210.74M
105 days until earnings call
Intraday BUY SELL Signals
Go to the list of all blogs
Allana's Avatar
published in Blogs
Feb 11, 2019
Cannabis company Aurora first to export to U.K.

Cannabis company Aurora first to export to U.K.

Ahead of its earnings after the closing bell, cannabis-producer Aurora says it has shipped a batch of cannabis oil to the U.K. The company also says that it was one of the first Canadian licensed pot producers to export product to the U.K., which allows specialist doctors to issue prescriptions for cannabis-based medicine.

Closer to home, Aurora and competitor Canopy have established a complex scheme that gives them the ability to acquire a majority stake in several U.S. companies that they once owned, should the federal government legalize marijuana.

Related Ticker: ACB

ACB in upward trend: price may ascend as a result of having broken its lower Bollinger Band on February 04, 2026

ACB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where ACB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ACB's RSI Oscillator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on March 04, 2026. You may want to consider a long position or call options on ACB as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACB just turned positive on February 19, 2026. Looking at past instances where ACB's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACB advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where ACB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACB entered a downward trend on February 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.528) is normal, around the industry mean (25.870). P/E Ratio (19.440) is within average values for comparable stocks, (74.862). ACB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.017). ACB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (0.751) is also within normal values, averaging (113.396).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ACB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands Inc. (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Journey Medical Corp (NASDAQ:DERM), Aurora Cannabis (NASDAQ:ACB).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.91B. The market cap for tickers in the group ranges from 2.12K to 64.54B. MKKGY holds the highest valuation in this group at 64.54B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was -3%. For the same Industry, the average monthly price growth was 30%, and the average quarterly price growth was 1%. BIOE experienced the highest price growth at 65%, while EAPIF experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was 20%. For the same stocks of the Industry, the average monthly volume growth was -30% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 65
Price Growth Rating: 60
SMR Rating: 78
Profit Risk Rating: 90
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
ACB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACB showed earnings on February 04, 2026. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a licensed producer of medical marijuana in Canada

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3498 63 Avenue
Phone
+1 855 279-4652
Employees
1130
Web
https://www.auroramj.com
Interact to see
Advertisement
Tickeron, a leader in AI-driven financial tools, today announced exceptional results from its AI Trading Agents, showcasing annualized returns ranging from 102% to 210% across various high-liquidity stocks and strategies.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced groundbreaking performance from its suite of AI Trading Agents. Powered by Financial Learning Models (FLMs), these agents have demonstrated exceptional returns, with top performers achieving annualized gains of up to 83% over periods ranging from 127 to 390 days.
#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, today unveils its Top 10 Day Traders: AI Trading Robots, showcasing exceptional performance in volatile markets. Powered by advanced Financial Learning Models (FLMs), these robots integrate AI with technical analysis to deliver real-time insights for day traders.
#artificial_intelligence
Tickeron, a leader in AI-driven financial solutions, announces groundbreaking performance results for its Crypto AI Trading Robots, achieving annualized returns of up to 85% for ETH.X, 56% for OM.X, and 49% for XRP.X in 2025, powered by advanced Financial Learning Models (FLMs).
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced groundbreaking results from its AI Trading Agents, showcasing annualized returns as high as +84% across various stocks and portfolios.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced the launch of its advanced AI Trading Agents. These innovative brokerage agents provide real-time trading signals powered by machine learning, utilizing tick-level brokerage data and precise trade amounts across 5-, 15-, and 60-minute timeframes.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, today announced groundbreaking results from its AI Trading Agents, showcasing exceptional performance in real-time trading signals powered by machine learning. Utilizing tick-level brokerage data and precise trade amounts, these agents operate on 5-, 15-, and 60-minute timeframes to provide traders with actionable insights in volatile markets.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, today announced the launch of its advanced AI Trading Agents. These cutting-edge brokerage agents deliver real-time trading signals powered by machine learning, leveraging tick-level brokerage data and precise trade amounts across 5-, 15-, and 60-minute timeframes. Designed to empower traders with superior insights, the agents have demonstrated exceptional performance, including annualized returns as high as 82%.
#artificial_intelligence
The financial markets have undergone a profound transformation in recent years, driven by the integration of artificial intelligence (AI) into trading strategies. As a financial analyst, writer, and AI specialist, one observes that AI trading agents represent a pinnacle of this evolution, blending machine learning algorithms with real-time data analysis to execute trades with unprecedented precision.
#artificial_intelligence
AI trading represents a revolutionary shift in how financial markets operate, combining artificial intelligence, machine learning, and sophisticated algorithmic trading strategies to execute trades with unprecedented precision and speed.
#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, today announced exceptional trading results from its AI Trading Agent focused on Hubbell Incorporated (HUBB). The agent, operating on a 5-minute timeframe, delivered a +105% annualized return, starting from an initial balance of $100,000.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced the launch of its advanced AI Trading Agents, delivering real-time trading signals and sophisticated money management for retail and institutional traders. Powered by Financial Learning Models (FLMs) and machine learning, these agents operate across 5-, 15-, and 60-minute timeframes, achieving annualized returns of up to 145% on select portfolios.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, today announced the exceptional performance of its AI Trading Agents, achieving annualized returns of up to 162%, profitable trade percentages as high as 90.51%, and a robust profit factor across multiple assets.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, proudly announces the exceptional performance of its AI Trading Agents, delivering annualized returns of up to 188% on a 5-minute timeframe.
#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, today announced the launch of its advanced Pattern Search Engine (PSE), a revolutionary platform that scans 39 distinct trading patterns across stocks, penny stocks, ETFs, crypto, and forex.
#artificial_intelligence
AI trading bots represent the pinnacle of financial technology innovation, transforming how traders and investors interact with global markets.
#artificial_intelligence
As a financial analyst, writer, and AI specialist, I've always pushed for innovations that merge artificial intelligence with actionable trading tools. In the fast-paced world of modern markets, where volatility demands quick decisions, Tickeron's new "My Trades Aggregator (from AI Robots Followed)" aggregator stands out as a revolutionary feature.
#artificial_intelligence#trading
Tickeron, a leading provider of AI-driven trading solutions, is thrilled to announce the exceptional performance of its AI Trading Agents, delivering outstanding results across multiple high-profile stocks.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technologies, today announced groundbreaking results from its AI Crypto Trading Virtual Agents. These innovative tools provide real-time trading signals, integrated money management, and customizable balances, all powered by advanced machine learning algorithms operating on 5-, 15-, and 60-minute timeframes.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technologies, today announced the launch of its advanced AI Trading Brokerage Agents. These cutting-edge tools deliver real-time trading signals powered by machine learning, utilizing tick-level brokerage data and precise trade amounts across 5-, 15-, and 60-minute timeframes.
#artificial_intelligence